Artelo Biosciences Inc's Customers Performance

Name: Artelo Biosciences Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

ARTL

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


ARTL's Source of Revenues		• List of ARTL Customers

for the same period Artelo Biosciences Inc

• List of ARTL Customers

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Artelo Biosciences Inc's Comment on Sales, Marketing and Customers

News about Artelo Biosciences Inc Contracts

Artelo Biosciences Breakthrough: ART12.11 Shows Comparable Pharmacokinetics to Epidiole...

Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24 Artelo Biosciences Inc., a leading biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics, has recently showcased highly promising data for their novel investigational therapy, ART12.11, at the CT-CANN24 conference. The data presented highlight significant strides towards developing a solid dosage form of ART12.11, spotlighting its potential in the clinical therapeutics landscape. ART12.11: A Promising Therapeutic AgentART12.11 is part of Artelo’s innovative treatment pipeline targeting a range of medical conditions. This investigational thera...

A Comprehensive Examination of FABP7 as a Novel Target in Cancer Therapy and Artelo Biosciences' Role in FABP Inhibitor Development

:This article presents an in-depth review of Artelo Biosciences Inc. s recent peer-reviewed publication highlighting Fatty Acid Binding Protein 7 (FABP7) as a potential game-changer in cancer therapy and offers further evidence of the various avenues for FABP inhibitor development for various severe health conditions, including cancer.Artelo Biosciences Inc. s commitment to the continuous exploration and development of pharmaceutical treatments for cancer and other severe health conditions is fully depicted in their recent studies on Fatty Acid Binding Protein 7 (FABP7), showing the great potential this biological protein possesses as a novel target in cancer therapy. Henceforth, an unambiguous understanding...

ARTL's Stock Performance relative to it's Customers

ARTL's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Artelo Biosciences Inc	1.73	0.00	-13.47	7
SUBTOTAL	0.00	0.00	0.00	-

Sources: Artelo Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Artelo Biosciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Artelo Biosciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.